Goldman Sachs
RXII

Goldman Sachs’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Goldman Sachs’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-60,000
Closed -$184K – 7519
2014
Q2 		$184K Buy
+60,000
New +$184K ﹤0.01% 6259

Goldman Sachs's RXII Position: Q4 2016 in Review

Goldman Sachs sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 1,472,527 shares — an estimated $516K sold.

Goldman Sachs first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $823K in Q2 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Goldman Sachs reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Goldman Sachs sold 1,472,527 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $516K.
  • Goldman Sachs first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
  • Goldman Sachs's GALENA BIOPHARMA INC COM position peaked at $823K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Goldman Sachs's 13F filing for Q4 2016, filed 14 Feb 2017.